MEDPLUS Medplus Health Services Q4 FY25 results (Jan–Mar 2025) and concall
Medplus Health reported a robust Q4 and FY25, with consolidated revenue reaching INR61,361 million for the full year and operating EBITDA at INR2,776 million. The Diagnostics segment achieved profitability, turning around from a loss in the previous year. The company added 305 net stores in FY25 and aims for 600 in FY26, while focusing on private label growth and strengthening backend operations to drive margin expansion and sustainable growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 156 | 177 | 202 |
| EBITDA | 17 | 19 | 24 |
| Net profit | 8 | 9 | 14 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
